Description
Retatrutide (LY3437943) is a novel triple agonist peptide targeting the GIP, GLP-1, and glucagon receptors simultaneously. As a next-generation compound in the incretin mimetic class, it has drawn significant interest in metabolic and obesity research for its multi-receptor activity profile.
Each vial contains 10mg of lyophilized retatrutide, third-party tested for purity and identity.
We participate in a cooperative purchasing group in which members pool resources to conduct batch testing together, keeping verification costs manageable without compromising standards.
Orders are processed and shipped withing 48 hours.
Specifications
- Sequence: Modified incretin peptide
- Molecular Weight: ~4.8 kDa
- Form: Lyophilized powder
- Purity: ≥99%
- Storage: Keep refrigerated. Use appropriate reconstitution protocols per your research requirements.
For research purposes only. Not for human use. Not for veterinary use.
